Literature DB >> 11911594

Mapping neutralizing and non-neutralizing epitopes on the capsid protein of feline calicivirus.

K Geissler1, K Schneider, U Truyen.   

Abstract

Neutralizing epitopes on feline calicivirus (FCV) capsid protein were mapped using chimeric capsid proteins recombinant between two FCV isolates that do not show any cross-neutralization. The three chimeric proteins examined were expressed in murine L929 cells employing an MVA/T7 vaccinia virus expression system and inoculated into major histocompatibility complex haplotype-matched C3/HN mice. Based on the neutralizing antibody titre the neutralizing epitope(s) could be mapped to the 5' hypervariable region of the E region or potentially to the C region. The epitopes of some non-neutralizing antibodies were mapped with the same chimeric proteins to the regions B or D and F of the FCV capsid protein.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11911594     DOI: 10.1046/j.1439-0450.2002.00529.x

Source DB:  PubMed          Journal:  J Vet Med B Infect Dis Vet Public Health        ISSN: 0931-1793


  14 in total

1.  Genogrouping of vaccine breakdown strains (VBS) of feline calicivirus in Japan.

Authors:  K Ohe; S Sakai; T Takahasi; F Sunaga; M Murakami; A Kiuchi; M Fukuyama; K Furuhata; M Hara; Y Ishikawa; A Taneno
Journal:  Vet Res Commun       Date:  2007-05       Impact factor: 2.459

2.  FCV-VBS isolated from cats with typical symptoms caused VSD in experimental cats.

Authors:  Kyoko Ohe; Toshikazu Takahashi; Daisuke Hara; Motonobu Hara
Journal:  Vet Res Commun       Date:  2007-09-25       Impact factor: 2.459

3.  Characterization of a broadly reactive monoclonal antibody against norovirus genogroups I and II: recognition of a novel conformational epitope.

Authors:  Tomoyuki Shiota; Michio Okame; Sayaka Takanashi; Pattara Khamrin; Makiko Takagi; Kenji Satou; Yuichi Masuoka; Fumihiro Yagyu; Yuko Shimizu; Hideki Kohno; Masashi Mizuguchi; Shoko Okitsu; Hiroshi Ushijima
Journal:  J Virol       Date:  2007-09-12       Impact factor: 5.103

4.  Characterization of a Vesivirus Associated with an Outbreak of Acute Hemorrhagic Gastroenteritis in Domestic Dogs.

Authors:  Randall W Renshaw; Jennifer Griffing; Jaime Weisman; Lisa M Crofton; Melissa A Laverack; Robert P Poston; Gerald E Duhamel; Edward J Dubovi
Journal:  J Clin Microbiol       Date:  2018-04-25       Impact factor: 5.948

5.  Identification of Genogroup I and Genogroup II broadly reactive epitopes on the norovirus capsid.

Authors:  Tracy Dewese Parker; Noritoshi Kitamoto; Tomoyuki Tanaka; Anne M Hutson; Mary K Estes
Journal:  J Virol       Date:  2005-06       Impact factor: 5.103

6.  High genetic diversity of the immunodominant region of the feline calicivirus capsid gene in endemically infected cat colonies.

Authors:  Alan D Radford; Susan Dawson; Ruth Ryvar; Karen Coyne; Deborah R Johnson; Michael B Cox; Els F J Acke; Diane D Addie; Rosalind M Gaskell
Journal:  Virus Genes       Date:  2003-10       Impact factor: 2.332

7.  Application of chimeric feline foamy virus-based retroviral vectors for the induction of antiviral immunity in cats.

Authors:  Astrid Schwantes; Uwe Truyen; Joachim Weikel; Christian Weiss; Martin Löchelt
Journal:  J Virol       Date:  2003-07       Impact factor: 5.103

8.  Detection of feline calicivirus (FCV) from vaccinated cats and phylogenetic analysis of its capsid genes.

Authors:  K Ohe; S Sakai; F Sunaga; M Murakami; A Kiuchi; M Fukuyama; K Furuhata; M Hara; T Soma; Y Ishikawa; A Taneno
Journal:  Vet Res Commun       Date:  2006-04       Impact factor: 2.816

Review 9.  Feline foamy virus-based vectors: advantages of an authentic animal model.

Authors:  Weibin Liu; Janet Lei; Yang Liu; Dragana Slavkovic Lukic; Ann-Mareen Räthe; Qiuying Bao; Timo Kehl; Anne Bleiholder; Torsten Hechler; Martin Löchelt
Journal:  Viruses       Date:  2013-07-12       Impact factor: 5.048

10.  In vivo comparison of two human norovirus surrogates for testing ethanol-based handrubs: the mouse chasing the cat!

Authors:  Syed A Sattar; Mohammad Ali; Jason A Tetro
Journal:  PLoS One       Date:  2011-02-24       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.